GRI GRI Bio Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: GRI

Price (delayed)

$0.41

Market cap

$1.31M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$28.25

Enterprise value

-$483,440

Highlights
GRI Bio's debt has plunged by 98% YoY and by 50% from the previous quarter
The net income has grown by 3.8% from the previous quarter
The equity has soared by 116% YoY but it has plunged by 88% from the previous quarter
GRI Bio's EPS has increased by 45% from the previous quarter but it has decreased by 13% YoY
GRI's quick ratio has shrunk by 58% QoQ
Sector: Healthcare
Industry: Biotechnology
Peers: OMER OMGA

Key stats

What are the main financial stats of GRI
Market
Shares outstanding
3.2M
Market cap
$1.31M
Enterprise value
-$483,440
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.73
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$10.96M
EBITDA
-$10.95M
Free cash flow
-$9M
Per share
EPS
-$28.25
Free cash flow per share
-$19.49
Book value per share
$0.56
Revenue per share
$0
TBVPS
$6.4
Balance sheet
Total assets
$2.96M
Total liabilities
$2.7M
Debt
$14,000
Equity
$259,000
Working capital
$237,000
Liquidity
Debt to equity
0.05
Current ratio
1.09
Quick ratio
0.67
Net debt/EBITDA
0.16
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-345.4%
Return on equity
-795.5%
Return on invested capital
N/A
Return on capital employed
-4,229.7%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GRI stock price

How has the GRI Bio stock price performed over time
Intraday
-6.82%
1 week
-4.65%
1 month
-22.05%
1 year
-99.24%
YTD
-84.78%
QTD
-46.05%

Financial performance

How have GRI Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$11.39M
Net income
-$13.04M
Gross margin
N/A
Net margin
N/A
GRI Bio's operating income has increased by 8% from the previous quarter
The net income has grown by 3.8% from the previous quarter

Growth

What is GRI Bio's growth rate over time

Valuation

What is GRI Bio stock price valuation
P/E
N/A
P/B
0.73
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GRI Bio's EPS has increased by 45% from the previous quarter but it has decreased by 13% YoY
The equity has soared by 116% YoY but it has plunged by 88% from the previous quarter
The price to book (P/B) is 98% lower than the last 4 quarters average of 41.8

Efficiency

How efficient is GRI Bio business performance
GRI's ROE is up by 31% QoQ
The company's return on assets rose by 20% QoQ

Dividends

What is GRI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GRI.

Financial health

How did GRI Bio financials performed over time
GRI's total assets is 10% more than its total liabilities
GRI's quick ratio has shrunk by 58% QoQ
The current ratio has declined by 46% since the previous quarter
GRI Bio's debt is 95% less than its equity
The equity has soared by 116% YoY but it has plunged by 88% from the previous quarter
GRI's debt to equity has soared by 112% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.